Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis

Table 3 Comparison of liver function indexes between the two groups of patients (mean ± SD)

Index	Research group (n = 44)	Control group (n = 44)	t value	P value
ALT (U/L)
Preoperative	33.04 ± 8.56	34.72 ± 8.11	-0.945	0.347
24 h after operation	378.61 ± 77.49a	430.58 ± 83.67a	-3.023	0.003
72 h after operation	246.13 ± 54.06a	281.35 ± 59.61a	-2.903	0.005
AST (U/L)
Preoperative	29.61 ± 7.21	27.30 ± 7.85	1.438	0.154
24 h after operation	355.30 ± 69.50a	416.49 ± 73.03a	-4.026	0.000
72 h after operation	223.47 ± 48.64a	248.62 ± 50.10a	-2.389	0.019
TBIL (μmol/L)
Preoperative	15.92 ± 4.40	15.28 ± 4.71	0.659	0.512
24 h after operation	32.85 ± 7.01a	34.06 ± 8.43a	-0.732	0.466
72 h after operation	20.46 ± 5.83a	22.90 ± 6.15a	-1.910	0.059
PA (mg/dL)
Preoperative	313.86 ± 46.91	320.74 ± 51.67	-0.654	0.515
24 h after operation	194.82 ± 32.65a	188.57 ± 29.48a	0.942	0.349
72 h after operation	275.12 ± 41.81a	269.84 ± 46.10a	0.563	0.575

^aP < 0.05 vs this group before surgery.

ALT: Alanine transaminase; AST: Aspartate aminotransferase; TBIL: Total bilirubin; PA: Prealbumin.